Navigation Links
Encision Enters Into Sales Representation Agreement With Caldera Medical
Date:3/25/2009

BOULDER, Colo., March 25 /PRNewswire-FirstCall/ -- Encision Inc. ("Encision") (OTC Bulletin Board: ECIA), a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, has entered into an agreement with Caldera Medical, Inc. ("Caldera") to represent Caldera's line of products. Caldera's products include the Desara(R) Sling System for treating stress urinary incontinence which is estimated to affect 15 million women in the U.S. Encision will use its sales employees to supplement Caldera's sales team in introducing Caldera's products to physicians and hospitals.

"We are pleased to expand our product offerings to a key group of our target customers. Caldera's products are consistent with our desire to offer 'best in class' products to the surgical market," said Jack Serino, President and CEO of Encision.

"Through Encision's experienced sales representatives, we will expand coverage throughout the U.S. market and strengthen our presence in the marketplace. This is especially important as we continue to broaden our product portfolio with innovative new technologies," said Bryon L. Merade, CEO of Caldera.

About Encision:

Encision designs, develops, manufactures and markets innovative surgical devices that allow surgeons to optimize technique and patient safety during a broad range of surgical procedures. Based in Boulder, Colorado, the Company pioneered the development of patented AEM(R) Laparoscopic Instruments to improve electrosurgery and reduce the chance for patient injury in minimally invasive surgery. For more information, visit Encision's web site at www.encision.com.

About Caldera:

Caldera is dedicated to bringing innovative medical devices to the marketplace. Caldera focuses exclusively on differentiated, high-impact products across the gynecology,
'/>"/>

SOURCE Encision Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Encision Launches Next Generation of EnTouch(R) Handles for Advanced Laparoscopic Procedures
2. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
3. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
4. Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
5. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
6. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
7. GeneGo Enters Multi-Year Agreement With Bristol Myers Squibb for Access to GeneGo Software Suite and Databases
8. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
9. NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
10. Elbit Medical Imaging Ltd. Announces that Plaza Centers Has Entered into a Joint Venture Partnership to Develop Residential and Office Projects in Romania
11. Sangui Partnership Enters a New Phase:
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... TEL AVIV, Israel , May 24, 2013 ... (NYSE MKT: NSPR), a leader in embolic protection stents, announced ... and Chief Executive Officer, and Craig Shore ... Benchmark Company, LLC One-on-One Investor Conference on Thursday May 30, ... Milwaukee, WI. The format of ...
(Date:5/24/2013)... Texas (PRWEB) May 24, 2013 ... benchmarking survey on kinase profiling carried out in ... details of the breakdown of the responses for ... the future (2015). It also highlights some interesting ... survey groupings. Two bottom-up models were developed to ...
(Date:5/24/2013)... 24, 2013 The Oklahoma tornado ... its ravage, the mayor of Moore, one of the heavily ... said a report from cnn.com. Reaching out to also be ... Molderizer and Safe Shield to counter the looming mold problem. ... on May 22, 2013, caused 24 deaths, My Cleaning Products ...
(Date:5/24/2013)... Quincy Bioscience, a leading research company ... proteins to support healthy living, is pleased to ... apoaequorin in Food and Chemical Toxicology ... Industrial Biological Research Association. , The objective ... effects, if any, of apoaequorin, in rats following ...
Breaking Biology Technology:InspireMD To Participate In Benchmark Investor Conference On May 30th 2InspireMD To Participate In Benchmark Investor Conference On May 30th 3InspireMD To Participate In Benchmark Investor Conference On May 30th 4Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 3Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 4Mayor of Oklahoma-Tornado-Impaired Town Proposes Storm Shelter Bill, My Cleaning Products Offers Complimentary Molderizer and Safe Shield to Help Victim with Looming Mold 2Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2
... Realty Trust, Inc. (NYSE: BMR ) today announced ... 30, 2010 after the market closes on Wednesday, November 3, ... Executive Officer, Kent Griffin, President, and Greg N. Lubushkin, Chief ... a.m. Pacific Time on Thursday, November 4, 2010 to discuss ...
... 18 Reportlinker.com announces that a new market research ... Global Food Safety Testing Industry ... markets for Food Safety Testing in US$ Million by ... GMO Testing, and Other Testing. The end-use markets also ...
... Oct. 18 NeurogesX, Inc. (Nasdaq: NGSX ... novel pain management therapies, today announced plans to pursue ... to include patients with painful HIV-associated neuropathy (HIV-AN, also ... Following a recent meeting with the U.S. Food ...
Cached Biology Technology:BioMed Realty Trust to Report 2010 Third Quarter Results 2Reportlinker Adds Global Food Safety Testing Industry 2Reportlinker Adds Global Food Safety Testing Industry 3Reportlinker Adds Global Food Safety Testing Industry 4Reportlinker Adds Global Food Safety Testing Industry 5Reportlinker Adds Global Food Safety Testing Industry 6Reportlinker Adds Global Food Safety Testing Industry 7Reportlinker Adds Global Food Safety Testing Industry 8Reportlinker Adds Global Food Safety Testing Industry 9Reportlinker Adds Global Food Safety Testing Industry 10Reportlinker Adds Global Food Safety Testing Industry 11Reportlinker Adds Global Food Safety Testing Industry 12Reportlinker Adds Global Food Safety Testing Industry 13Reportlinker Adds Global Food Safety Testing Industry 14Reportlinker Adds Global Food Safety Testing Industry 15Reportlinker Adds Global Food Safety Testing Industry 16Reportlinker Adds Global Food Safety Testing Industry 17Reportlinker Adds Global Food Safety Testing Industry 18Reportlinker Adds Global Food Safety Testing Industry 19Reportlinker Adds Global Food Safety Testing Industry 20Reportlinker Adds Global Food Safety Testing Industry 21Reportlinker Adds Global Food Safety Testing Industry 22Reportlinker Adds Global Food Safety Testing Industry 23NeurogesX to Pursue Expanded U.S. Label for Qutenza® (capsaicin) 8% Patch in HIV-Associated Neuropathy 2NeurogesX to Pursue Expanded U.S. Label for Qutenza® (capsaicin) 8% Patch in HIV-Associated Neuropathy 3NeurogesX to Pursue Expanded U.S. Label for Qutenza® (capsaicin) 8% Patch in HIV-Associated Neuropathy 4
(Date:5/23/2013)... Automated conserved noncoding sequence (CNS) discovery reveals differences ... , Within the genome of each species, there are ... in position and sequence over millions of years, but ... evolutionarily stable sequences, so-called conserved noncoding sequences (CNSs), are ... the condensation of chromosomes, but the function of many ...
(Date:5/23/2013)... suppresses lipid synthesis in the liver, UC Irvine endocrinologists ... liver diseases. , With this finding, Dr. Ellis ... in the field. Study results appear in the May ... , "The dogma in the steroid receptor field for ... the nucleus respond to steroid hormones by regulating genes ...
(Date:5/23/2013)... treating cerebral palsy with autologous cord blood. Following a ... old boy had been in a persistent vegetative state ... after treatment with the cord blood containing stem cells, ... child learned to speak simple sentences and to move. ... dispel the long-held doubts about the effectiveness of the ...
Breaking Biology News(10 mins):Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2First successful treatment of pediatric cerebral palsy with autologous cord blood 2
... State University research group is jumping ahead to improve ... childhood obesity. The researchers -- led by David ... a program called HOP,N Home, which stands for Healthy ... researchers have been working on obesity prevention for more ...
... 16, 2011 For the first time, researchers ... effects of the enzymes involved in degrading persistent ... by Professor Michel Sylvestre of Centre INRSInstitut Armand-Frappier ... serve not only to help develop effective biocatalysts ...
... is widely suspected that the current wave of obesity among ... diabetes over the next few decades. But a second systematic ... adult life has shown there is little evidence of a ... remove any risk of lasting harm. This ...
Cached Biology News:Research aims to prevent obesity by reaching parents, young children through child care 2Research aims to prevent obesity by reaching parents, young children through child care 3Childhood obesity -- what are the health risks? 2Childhood obesity -- what are the health risks? 3
... Description: 100 g ... 70 kDa YAP from Human/mouse/rat samples. ... Research Focus: ... -20C Shipping ...
...
... M-PER Mammalian Protein Extraction Reagent ... lysis solution that means no ... no sonication! With M-PER Reagent, ... five minutes at room temperature, ...
Application: for RNase- decontamination , Registered Trademark of Ambion. ,Special grade: for molecular biology Density: 1.00 g/mL (20 C) Suitab tst: RNase decontamination in accordance...
Biology Products: